Brian Peter Zambrowicz
Directeur/Bestuurslid bij Texas A&M Institute for Genomic Medicine
Actieve functies van Brian Peter Zambrowicz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Texas A&M Institute for Genomic Medicine
 Texas A&M Institute for Genomic Medicine Miscellaneous Commercial ServicesCommercial Services Texas A&M Institute for Genomic Medicine focuses in research and development for medical industry. It was founded in 2006 and is headquartered in College Station, Texas. | Directeur/Bestuurslid | - | - |
Loopbaan van Brian Peter Zambrowicz
Eerdere bekende functies van Brian Peter Zambrowicz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-1995 | 24-02-2015 |
| Oprichter | 07-07-1995 | 24-02-2015 | |
| NUEVOLUTION AB (PUBL) | Directeur/Bestuurslid | - | - |
| Corporate Officer/Principal | - | - |
Opleiding van Brian Peter Zambrowicz
| University of Washington | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Denemarken | 2 |
Operationeel
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Texas A&M Institute for Genomic Medicine
Texas A&M Institute for Genomic Medicine Miscellaneous Commercial ServicesCommercial Services Texas A&M Institute for Genomic Medicine focuses in research and development for medical industry. It was founded in 2006 and is headquartered in College Station, Texas. | Commercial Services |
